Oranogenesis Holdings (ORGO) PT Raised to $3.80 at Cantor Fitzgerald
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/24/2026
Go back to Oranogenesis Holdings (ORGO) PT Raised to $3.80 at Cantor Fitzgerald
November 12, 2024 4:33 PM EST
Organogenesis Holding (NASDAQ: ORGO) reported Q3 EPS of $0.09, $0.11 better than the analyst estimate of ($0.02). Revenue for the quarter came in at $115.2 million versus the consensus estimate of $108.83 million.
GUIDANCE:
Organogenesis Holding sees FY2024 revenue of $455-480 million, versus the consensus of $456... More
November 12, 2024 4:01 PM EST
Organogenesis Holdings Inc. (Nasdaq: ORGO), a leading regenerative medicine company focused on the development, manufacture, and commercialization of product solutions for the Advanced Wound Care and Surgical & Sports Medicine markets, today announced that it has entered into a Subscription Agreement with affiliates of Avista Healthcare Partners (Investors) for the sale of its Series A Convertible Preferred Stock (Preferred Stock) in a private placement for gross proceeds of $130 million to the Company, prior to deducting placement agent commissions, fees and other offering expenses.
The Company intends to use the net proceeds from the private... More
